LIOPYLIOPYOTC
Loading
EBITDA Margin Over TimeStable
Percentile Rank93
3Y CAGR+2.8%
5Y CAGR-2.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+2.8%/yr
vs +3.9%/yr prior
5Y CAGR
-2.9%/yr
Recent acceleration
Acceleration
-1.2pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM13.68%+4.2%
202413.13%+21.8%
202310.78%-14.5%
202212.60%-4.8%
202113.24%-16.6%
202015.86%+31.0%
201912.11%+12.1%
201810.80%+10.9%
20179.74%+11.2%
20168.76%-